![]() |
|
|
Vol. 11, Issue 10, 3589-3599, October 2000
Department of Chemistry and Biochemistry, and Center for Molecular
Genetics, University of California, San Diego, La Jolla, California
92093-0367
Ligand binding to receptor tyrosine kinases (RTKs) regulates
receptor dimerization and activation of the kinase domain. To examine
the role of the transmembrane domain in regulation of RTK activation,
we have exploited a simplified transmembrane motif, [VVVEVVV]n, previously shown to activate the Neu
receptor. Here we demonstrate rotational linkage of the transmembrane
domain with the kinase domain, as evidenced by a periodic activation of
Neu as the dimerization motif is shifted across the transmembrane domain. These results indicate that activation requires a specific orientation of the kinase domains with respect to each other. Results
obtained with platelet-derived growth factor receptor-
suggest that this rotational linkage of the transmembrane domain to the
kinase domain may be a general feature of RTKs. These observations suggest that activating mutations in RTK transmembrane and
juxtamembrane domains will be limited to those residues that position
the kinase domains in an allowed rotational conformation.
Corresponding author: E-mail address:
ddonoghue{at}ucsd.edu.
This article has been cited by other articles:
![]() |
D. Dell'Era Dosch and K. Ballmer-Hofer Transmembrane domain-mediated orientation of receptor monomers in active VEGFR-2 dimers FASEB J, January 1, 2010; 24(1): 32 - 38. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Finger, C. Escher, and D. Schneider The Single Transmembrane Domains of Human Receptor Tyrosine Kinases Encode Self-Interactions Sci. Signal., September 22, 2009; 2(89): ra56 - ra56. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. B. Trarbach, E. M. F. Costa, B. Versiani, M. de Castro, M. T. M. Baptista, H. M. Garmes, B. B. de Mendonca, and A. C. Latronico Novel Fibroblast Growth Factor Receptor 1 Mutations in Patients with Congenital Hypogonadotropic Hypogonadism with and without Anosmia J. Clin. Endocrinol. Metab., October 1, 2006; 91(10): 4006 - 4012. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Lerdrup, A. M. Hommelgaard, M. Grandal, and B. van Deurs Geldanamycin stimulates internalization of ErbB2 in a proteasome-dependent way J. Cell Sci., January 1, 2006; 119(1): 85 - 95. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bennasroune, M. Fickova, A. Gardin, S. Dirrig-Grosch, D. Aunis, G. Cremel, and P. Hubert Transmembrane Peptides as Inhibitors of ErbB Receptor Signaling Mol. Biol. Cell, July 1, 2004; 15(7): 3464 - 3474. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Houliston, R. S. Hodges, F. J. Sharom, and J. H. Davis Characterization of the Proto-oncogenic and Mutant Forms of the Transmembrane Region of Neu in Micelles J. Biol. Chem., June 4, 2004; 279(23): 24073 - 24080. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Voytyuk, J. Lennartsson, A. Mogi, G. Caruana, S. Courtneidge, L. K. Ashman, and L. Ronnstrand Src Family Kinases Are Involved in the Differential Signaling from Two Splice Forms of c-Kit J. Biol. Chem., March 7, 2003; 278(11): 9159 - 9166. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Fleishman, J. Schlessinger, and N. Ben-Tal A putative molecular-activation switch in the transmembrane domain of erbB2 PNAS, December 10, 2002; 99(25): 15937 - 15940. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. M. Nappi, J. A. Schaefer, and L. M. Petti Molecular Examination of the Transmembrane Requirements of the Platelet-derived Growth Factor beta Receptor for a Productive Interaction with the Bovine Papillomavirus E5 Oncoprotein J. Biol. Chem., November 27, 2002; 277(49): 47149 - 47159. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Irusta, Y. Luo, O. Bakht, C.-C. Lai, S. O. Smith, and D. DiMaio Definition of an Inhibitory Juxtamembrane WW-like Domain in the Platelet-derived Growth Factor beta Receptor J. Biol. Chem., October 4, 2002; 277(41): 38627 - 38634. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Yu, K. D. Sharma, T. Takahashi, R. Iwamoto, and E. Mekada Ligand-independent Dimer Formation of Epidermal Growth Factor Receptor (EGFR) Is a Step Separable from Ligand-induced EGFR Signaling Mol. Biol. Cell, July 1, 2002; 13(7): 2547 - 2557. [Abstract] [Full Text] [PDF] |
||||